Literature DB >> 19544621

Mitochondrial translocation of amyloid precursor protein and its cleaved products: relevance to mitochondrial dysfunction in Alzheimer's disease.

Hindupur K Anandatheerthavarada1, Latha Devi.   

Abstract

Alzheimer's disease (AD) is a multifactorial disorder. Mitochondrial dysfunction is one of the key characteristics of AD pathogenesis. However, the mechanisms underlying the progression of mitochondrial impairment during AD are not clear. Growing evidence suggests a causative role for intracellular accumulation of amyloid precursor protein (APP) and its proteolytic products in the pathogenesis of AD. Furthermore, APP possesses several domains including a mitochondrial targeting sequence. Recent literature suggests that mitochondrial localization of full length APP and its C-terminal proteolytically cleaved derivative beta amyloid (Abeta) are associated with the mitochondrial dysfunction. Here, we review the nature of mitochondrial localization of APP and Abeta and their pathological implications in AD mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19544621     DOI: 10.1515/revneuro.2007.18.5.343

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  8 in total

1.  Mitochondria-Mediated Moderation of Apoptosis by EGCG in Cytotoxic Neuronal Cells Induced by Lead (Pb) and Amyloid Peptides.

Authors:  Neelima Ayyalasomayajula; Lakshmi Jaya Madhuri Bandaru; Chellu S Chetty; Prasanna Kumar Dixit; Suresh Challa
Journal:  Biol Trace Elem Res       Date:  2021-11-19       Impact factor: 3.738

Review 2.  Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

Authors:  Latha Devi; Hindupur K Anandatheerthavarada
Journal:  Biochim Biophys Acta       Date:  2009-07-18

3.  Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity.

Authors:  Anne Eckert; Karen Schmitt; Jürgen Götz
Journal:  Alzheimers Res Ther       Date:  2011-05-05       Impact factor: 6.982

4.  Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes.

Authors:  Dolores Del Prete; Jan M Suski; Bénédicte Oulès; Delphine Debayle; Anne Sophie Gay; Sandra Lacas-Gervais; Renaud Bussiere; Charlotte Bauer; Paolo Pinton; Patrizia Paterlini-Bréchot; Mariusz R Wieckowski; Frédéric Checler; Mounia Chami
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.

Authors:  Loan Vaillant-Beuchot; Arnaud Mary; Raphaëlle Pardossi-Piquard; Alexandre Bourgeois; Inger Lauritzen; Fanny Eysert; Paula Fernanda Kinoshita; Julie Cazareth; Céline Badot; Konstantina Fragaki; Renaud Bussiere; Cécile Martin; Rosanna Mary; Charlotte Bauer; Sophie Pagnotta; Véronique Paquis-Flucklinger; Valérie Buée-Scherrer; Luc Buée; Sandra Lacas-Gervais; Frédéric Checler; Mounia Chami
Journal:  Acta Neuropathol       Date:  2020-10-20       Impact factor: 17.088

Review 6.  Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's Disease.

Authors:  Beata Pająk; Elżbieta Kania; Arkadiusz Orzechowski
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

Review 7.  Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update.

Authors:  Giovanna Cenini; Wolfgang Voos
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

Review 8.  Role of Mitochondrial Protein Import in Age-Related Neurodegenerative and Cardiovascular Diseases.

Authors:  Andrey Bogorodskiy; Ivan Okhrimenko; Dmitrii Burkatovskii; Philipp Jakobs; Ivan Maslov; Valentin Gordeliy; Norbert A Dencher; Thomas Gensch; Wolfgang Voos; Joachim Altschmied; Judith Haendeler; Valentin Borshchevskiy
Journal:  Cells       Date:  2021-12-14       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.